The “Problematic” Defense Acquisition Structure
The convoluted procedures by which the U.S. government purchases weapons and other military systems are rendered almost intelligible in a new report (pdf) from the Congressional Research Service.
The report introduces the defense acquisition structure, summarizes several recent analyses of that structure, and points towards some unfinished business.
“The unparalleled complexity of DOD’s defense acquisition structure lends itself to the continued emergence of many problematic issues,” the CRS report said.
“Simply put,” the House Armed Services Committee said last year, “the Department of Defense (DoD) acquisition process is broken… The rising costs and lengthening schedules of major defense acquisition programs lead to more expensive platforms fielded in fewer numbers.”
A copy of the new CRS report was obtained by Secrecy News.
See “Defense Acquisition: Overview, Issues, and Options for Congress,” June 4, 2007.
Nuclear weapons budgeting is like agreeing to buying a house without knowing the sales price, the mortgage rate, or the monthly payment.
Employing a living approach to evidence synthesis, disseminated at a national level, is a streamlined way to enable evidence-based decision-making nationwide.
By providing essential funding mechanisms, the Bioeconomy Finance Program will reduce the risks inherent in biotechnology innovation, encouraging more private sector investment.
While the U.S. has made significant advancements and remained a global leader in biotechnology over the past decade, the next four years will be critical in determining whether it can sustain that leadership.